- Home
- WIA vs KOD Comparison
WIA vs KOD Comparison
Compare WIA & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- KOD
- Stock Information
- Founded
- WIA 2003
- KOD 2009
- Country
- WIA United States
- KOD United States
- Employees
- WIA N/A
- KOD N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WIA Finance
- KOD Health Care
- Exchange
- WIA Nasdaq
- KOD Nasdaq
- Market Cap
- WIA 192.9M
- KOD 188.9M
- IPO Year
- WIA N/A
- KOD 2018
- Fundamental
- Price
- WIA $8.41
- KOD $3.83
- Analyst Decision
- WIA
- KOD Hold
- Analyst Count
- WIA 0
- KOD 3
- Target Price
- WIA N/A
- KOD $9.00
- AVG Volume (30 Days)
- WIA 39.2K
- KOD 282.5K
- Earning Date
- WIA 01-01-0001
- KOD 08-13-2025
- Dividend Yield
- WIA 12.29%
- KOD N/A
- EPS Growth
- WIA N/A
- KOD N/A
- EPS
- WIA N/A
- KOD N/A
- Revenue
- WIA N/A
- KOD N/A
- Revenue This Year
- WIA N/A
- KOD N/A
- Revenue Next Year
- WIA N/A
- KOD N/A
- P/E Ratio
- WIA N/A
- KOD N/A
- Revenue Growth
- WIA N/A
- KOD N/A
- 52 Week Low
- WIA $7.56
- KOD $1.92
- 52 Week High
- WIA $8.91
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- WIA 69.40
- KOD 52.03
- Support Level
- WIA $8.25
- KOD $3.70
- Resistance Level
- WIA $8.46
- KOD $4.01
- Average True Range (ATR)
- WIA 0.07
- KOD 0.22
- MACD
- WIA 0.01
- KOD 0.01
- Stochastic Oscillator
- WIA 78.26
- KOD 68.97
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.